Literature DB >> 22850880

Alarmins: awaiting a clinical response.

James K Chan1, Johannes Roth, Joost J Oppenheim, Kevin J Tracey, Thomas Vogl, Marc Feldmann, Nicole Horwood, Jagdeep Nanchahal.   

Abstract

Alarmins are endogenous molecules that are constitutively available and released upon tissue damage and activate the immune system. Current evidence indicates that uncontrolled and excessive release of alarmins contributes to the dysregulated processes seen in many inflammatory and autoimmune conditions, as well as tumorigenesis and cancer spread. Conversely, alarmins have also been found to play a major role in the orchestration of tissue homeostasis, including repair and remodeling in the heart, skin, and nervous system. Here, we provide an update and overview on alarmins, highlighting the areas that may benefit from this clinical translation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850880      PMCID: PMC3408740          DOI: 10.1172/JCI62423

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  148 in total

1.  S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.

Authors:  H Trøstrup; R Lundquist; L H Christensen; L N Jorgensen; T Karlsmark; B B Haab; M S Agren
Journal:  Br J Dermatol       Date:  2011-08       Impact factor: 9.302

2.  Heat shock proteins are no DAMPs, rather 'DAMPERs'.

Authors:  Femke Broere; Ruurd van der Zee; Willem van Eden
Journal:  Nat Rev Immunol       Date:  2011-07-25       Impact factor: 53.106

Review 3.  The potential roles for novel biomarkers in rheumatoid arthritis assessment.

Authors:  P J Mease
Journal:  Clin Exp Rheumatol       Date:  2011-06-30       Impact factor: 4.473

4.  Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock.

Authors:  Stéphanie Barnay-Verdier; Lakhdar Fattoum; Chloé Borde; Srini Kaveri; Sébastien Gibot; Vincent Maréchal
Journal:  Intensive Care Med       Date:  2011-02-26       Impact factor: 17.440

5.  Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis.

Authors:  Yasunobu Tamaki; Yuya Takakubo; Tomoyuki Hirayama; Yrjö T Konttinen; Stuart B Goodman; Mitsunori Yamakawa; Michiaki Takagi
Journal:  J Rheumatol       Date:  2011-02-15       Impact factor: 4.666

6.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 7.  Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation.

Authors:  Ori D Rotstein
Journal:  J Trauma       Date:  2003-05

8.  Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats.

Authors:  Keyue Liu; Shuji Mori; Hideo K Takahashi; Yasuko Tomono; Hidenori Wake; Toru Kanke; Yasuharu Sato; Norihito Hiraga; Naoto Adachi; Tadashi Yoshino; Masahiro Nishibori
Journal:  FASEB J       Date:  2007-07-12       Impact factor: 5.191

9.  HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3.

Authors:  Federica Limana; Grazia Esposito; Daniela D'Arcangelo; Anna Di Carlo; Sveva Romani; Guido Melillo; Antonella Mangoni; Chiara Bertolami; Giulio Pompilio; Antonia Germani; Maurizio C Capogrossi
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

10.  High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses.

Authors:  De Yang; Yuri V Postnikov; Yana Li; Poonam Tewary; Gonzalo de la Rosa; Feng Wei; Dennis Klinman; Theresa Gioannini; Jerrold P Weiss; Takashi Furusawa; Michael Bustin; Joost J Oppenheim
Journal:  J Exp Med       Date:  2011-12-19       Impact factor: 14.307

View more
  166 in total

Review 1.  Necroinflammation in Kidney Disease.

Authors:  Shrikant R Mulay; Andreas Linkermann; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

2.  O-linked sugars sound the alarm.

Authors:  Smita Gopinath; Yosuke Kumamoto; Akiko Iwasaki
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

Review 3.  Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.

Authors:  Peter Csermely; Tamás Korcsmáros; Ruth Nussinov
Journal:  Semin Cell Dev Biol       Date:  2016-07-06       Impact factor: 7.727

Review 4.  Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways.

Authors:  Daniel L Villeneuve; Brigitte Landesmann; Paola Allavena; Noah Ashley; Anna Bal-Price; Emanuela Corsini; Sabina Halappanavar; Tracy Hussell; Debra Laskin; Toby Lawrence; David Nikolic-Paterson; Marc Pallardy; Alicia Paini; Raymond Pieters; Robert Roth; Florianne Tschudi-Monnet
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

5.  A Non-Peptidic S100A9 Specific Ligand for Optical Imaging of Phagocyte Activity In Vivo.

Authors:  Tom Völler; Andreas Faust; Johannes Roth; Michael Schäfers; Thomas Vogl; Sven Hermann
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

6.  HMGB1 expression and muscle regeneration in idiopathic inflammatory myopathies and degenerative joint diseases.

Authors:  Karolina Cseri; János Vincze; Julianna Cseri; János Fodor; Zoltán Csernátony; László Csernoch; Katalin Dankó
Journal:  J Muscle Res Cell Motil       Date:  2015-03-12       Impact factor: 2.698

Review 7.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

8.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26

Review 9.  Reactive gliosis and the multicellular response to CNS damage and disease.

Authors:  Joshua E Burda; Michael V Sofroniew
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

10.  Patient-specific Immune States before Surgery Are Strong Correlates of Surgical Recovery.

Authors:  Gabriela K Fragiadakis; Brice Gaudillière; Edward A Ganio; Nima Aghaeepour; Martha Tingle; Garry P Nolan; Martin S Angst
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.